With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy||Fred Hutchinson Cancer Research Center / Colin Godwin, MD||Young Investigator Grants||2018||Washington|
|Immuno-therapeutic Targeting of CD56 in CBA2T3/GLIS2-AML in Children||Fred Hutchinson Cancer Research Center / Soheil Meshinchi, MD/PhD||Reach Grants||2018||Washington|
|MYC-driven Core Regulatory Circuits in Neuroblastoma||Dana-Farber Cancer Institute / Mark Zimmerman, PhD||Young Investigator Grants||2018||Massachusetts|
|Divergent Core Transcriptional Regulatory Circuitries to Highlight Context-Specific Vulnerabilities in AML||Dana-Farber Cancer Institute / Maxim Pimkin, MD/PhD||Young Investigator Grants||2018||Massachusetts|
|Modeling GATA2 Associated MDS/AML Predisposition Syndrome Using Color-Barcoding and Mutagenesis in Zebrafish||Dana-Farber Cancer Institute / Serine Avagyan, PhD||Young Investigator Grants||2018||Massachusetts|
|Targeting Oncogenic RAS in Pediatric Leukemia||Dana-Farber Cancer Institute / Loren Walensky, MD/PhD||Innovation Grants||2018||Massachusetts|
|Enhancing Communication about Sexual and Reproductive Health between Oncology Clinicians and Adolescent and Young Adults||Connecticut Children's Medical Center / Dr. Natasha Frederick, PhD||Psychosocial Launch Grant||2018||Connecticut|
|Circulating Repetitive Element RNAs as an Osteosarcoma Marker||Children's Hospital Los Angeles / David Cobrinik, MD/PhD||Innovation Grants||2018||California|
|Physical Properties of Drug-Resistant Leukemia Cells||Children's Hospital Los Angeles / Yong-mi Kim, MD/PhD||Innovation Grants||2018||California|
|Modeling and Therapeutic Targeting of p21-Activated Kinase Members in High-Risk Rhabdomyosarcoma||Baylor College of Medicine / Jason Yustein, MD/PhD||Innovation Grants||2018||Texas|